Amyloid in bone marrow smears of patients affected by multiple myeloma
✍ Scribed by Fara Petruzziello; Pio Zeppa; Lucio Catalano; Immacolata Cozzolino; Giuseppe Gargiulo; Pellegrino Musto; Fiorella D’Auria; Vincenzo Liso; Rita Rizzi; Nadia Caruso; Catello Califano; Eugenio Piro; Maurizio Musso; Vincenza Bonanno; Antonietta Pia Falcone; Salvatore Tafuto; Francesco Di Raimondo; Michelino De Laurentiis; Fabrizio Pane; Lucio Palombini; Bruno Rotoli
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 240 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Twenty-four patients with multiple myeloma received an allogeneic bone-marrow graft from HLAcompatible sibling donors (n = 23), or a twin donor (n = 1). Eighteen patients are alive, 1-36 months post bone-marrow transplantation (median 14 months). Ten of these patients had no signs ofmultiple myeloma